The pronounced decline of anti-SARS-CoV-2 spike trimeric IgG and RBD IgG in baseline seronegative individuals six months after BNT162b2 vaccination is consistent with the need for vaccine boosters
Gian Luca Salvagno, Brandon Michael Henry, Laura Pighi, Simone De Nitto, Gianluca Gianfilippi, Giuseppe Lippi
Abstract
Article The pronounced decline of anti-SARS-CoV-2 spike trimeric IgG and RBD IgG in baseline seronegative individuals six months after BNT162b2 vaccination is consistent with the need for vaccine boosters was published on January 1, 2022 in the journal Clinical Chemistry and Laboratory Medicine (CCLM) (volume 60, issue 2).
Topics & Concepts
MedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VaccinationSpike ProteinVirologyCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakBaseline (sea)Immunoglobulin GImmunologyAntibodyBiologyInternal medicineOutbreakDiseaseInfectious disease (medical specialty)FisherySARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingCOVID-19 Clinical Research Studies